Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 21, 2018
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - July 21, 2018

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

7/21/18 - As Seniors Across New York Continue to Face Soaring Prescription Drug Prices, Gillibrand Visits Watertown to Announce Legislation to Drive Down Costs and Increase Access to Safe, Affordable Medications
Kirsten Gillibrand, D- New York, issued the following news release:. U.S. Senator Kirsten Gillibrand today visited the Samaritan Medical Center to announce the Stop Price Gouging Act, which would drive down prescription drug prices, ensure access to affordable medications for New York seniors, and penalize drug companies that raise prices of medica
7/21/18 - BioClin Therapeutics Appoints Scott Myers as Chairman to its Board of Directors
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week BioClin Therapeutics, Inc., a privately-held clinical stage drug development company developing a first-in-class anti-FGFR3 monoclonal antibody in areas of high unmet medical need, announced the appointment of Scott D. Myers as chairman of Board of Directors. Mr. Myers was mo
7/21/18 - Clovis Oncology Receives EMA Validation for its Application for a New Indication for Rubraca? rucaparib as Maintenance Treatment for Women with...
By a News Reporter-Staff News Editor at Marketing Weekly News Clovis Oncology, Inc. announced that the European Medicines Agency has validated the application for a Type II variation to the marketing authorization for Rubraca to include maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary perito
7/21/18 - Contract Research Organization Market Hefty Growth with CAGR of 11.48% | Renowned Players as QuintilesIMS, PRA Health Sciences, ICON plc. Etc. by MRFR till 2023
"Contract Research Organization Market" Contract Research Organization Market Report include on MarketReseacrhFuture.com with Extensive Study. The report aims to provide an overview of Contract Research Organization Market Report. Detail analysis on possible segments and sub segments of the market. Forecast till 2023.
7/21/18 - FDA Approval of New Precision Medicine Therapy for Deadly Blood Cancer
The Leukemia and Lymphoma Society issued the following news release:. Progress in treating acute myeloid leukemia, a blood cancer that takes more than 10,000 lives in the United States each year, took an important step forward today with the U.S. Food& Drug Administration approval of ivosidenib for patients who have a specific genetic mutation call
7/21/18 - FDA Approves First Targeted Treatment for Patients With Relapsed or Refractory Acute Myeloid Leukemia Who Have a Certain Genetic Mutation
The U.S. Department of Health and Human Services' Food and Drug Administration issued the following news release:. "Tibsovo is a targeted therapy that fills an unmet need for patients with relapsed or refractory AML who have an IDH1 mutation," said Richard Pazdur, M.D., director of the FDA's Oncology Center of Excellence and acting director of the
7/21/18 - Glucosamine Market 2018 Global Growth, Opportunities and Industry Analysis Forecast to 2023: Glucosamine -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021
New York, NY 07/20/2018 Glucosamine Industry: Description- Wiseguyreports.Com Adds "Glucosamine- Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021" To Its Research Database. Glucosamine Market research report analyzes the market by Type and Application at global level and for each of the geographic regions-
7/21/18 - Hope for peanut allergies? Pills, patches, drops and even nuts themselves are being studied. [The News & Observer (Raleigh, N.C.)]
July 20 Every year, Americans make 30,000 emergency room visits because of food allergies, according to the Food and Drug Administration. Even touching a surface that previously held peanuts can trigger anaphylaxis, a life-threatening allergic reaction. This spring, Aimmune Therapeutics announced that it had wrapped up a 10- nation trial for its
7/21/18 - Johnson & Johnson to Present New Data for Investigational Preventive Vaccine, Single-Tablet Treatment Regimens for HIV-1 at AIDS 2018
Johnson and Johnson issued the following news release:. As part of its commitment to make HIV history, the Janssen Pharmaceutical Companies of Johnson& Johnson today announced that over ten company-sponsored and partnered presentations will be presented at the 22nd International AIDS Conference in Amsterdam, The Netherlands. Johnson& Johnson will a
7/21/18 - Patent Application Titled "Combination Therapy Using Belinostat and Pralatrexate to Treat Lymphoma" Published Online (USPTO 20180177783)
By a News Reporter-Staff News Editor at Investment Weekly News According to news reporting originating from Washington, D.C., by VerticalNews journalists, a patent application by the inventor Reddy, Guru, filed on June 14, 2016, was made available online on July 5, 2018. The assignee for this patent application is Spectrum Pharmaceuticals Inc..
7/21/18 - Patent Issued for Formulations of Bendamustine (USPTO 10010533)
By a News Reporter-Staff News Editor at Investment Weekly News A patent by the inventors Palepu, Nagesh R.; Buxton, Philip Christopher, filed on February 14, 2017, was published online on July 3, 2018, according to news reporting originating from Alexandria, Virginia, by VerticalNews correspondents. Patent number 10010533 is assigned to Eagle Pha
7/21/18 - Patent Issued for IL-33 Antagonists and Uses (USPTO 10011647)
By a News Reporter-Staff News Editor at Investment Weekly News From Alexandria, Virginia, VerticalNews journalists report that a patent by the inventors Murphy, Andrew J.; Papadopoulos, Nicholas J.; Orengo, Jamie M., filed on March 20, 2017, was published online on July 3, 2018. The patent's assignee for patent number 10011647 is Regeneron Pharma
7/21/18 - Patent Issued for Injector Training Device (USPTO 10013895)
By a News Reporter-Staff News Editor at Investment Weekly News A patent by the inventors Swanson, Kevin David; Sund, Julius, filed on March 12, 2014, was published online on July 3, 2018, according to news reporting originating from Alexandria, Virginia, by VerticalNews correspondents. Patent number 10013895 is assigned to Antares Pharma Inc..
7/21/18 - Peoria joins 13 other Illinois communities in opioid lawsuit filed against drug companies [Journal Star, Peoria, Ill.]
July 21 PEORIA The city of Peoria has joined 13 other Illinois municipalities and one fire protection district in a mass-action lawsuit filed in state court Thursday in Chicago against numerous drug manufacturers along with three Illinois doctors who ran a "pill mill." The lawsuit is the latest event in the national opioid epidemic that's seen
7/21/18 - Report Summarizes Biosimilars Study Findings from University of Pisa (Transitioning from first- to second-generation biosimilars: An appraisal of...
Report Summarizes Biosimilars Study Findings from University of Pisa. By a News Reporter-Staff News Editor at Marketing Weekly News Research findings on Drugs and Therapies- Biosimilars are discussed in a new report. The news correspondents obtained a quote from the research from the University of Pisa, "Based on these arguments, the present arti
7/21/18 - Takeda and TiGenix Announce Results of Second Acceptance Period for the Voluntary and Conditional Public Takeover Bid in respect of TiGenix and...
Takeda and TiGenix Announce Results of Second Acceptance Period for the Voluntary and Conditional Public Takeover Bid in respect of TiGenix and Commencement of Simplified Squeeze-out and Intention to Delist the ADSs from Nasdaq... View the full release here: https://www.businesswire.com/news/home/20180705005656/en/ Takeda and TiGenix Announce...
7/21/18 - Tasly enriches foreign portfolio [China Daily: Africa Weekly]
The total value of the deal is $24 million plus royalties and Tasly will pay $3 million to initiate the project and participate in the third phase of clinical tests and research with EA. Tasly also announced that it will buy stock worth $20 million in Australia- based pharmaceutical maker Mesoblast Ltd on Tuesday. If the products are approved by th
7/21/18 - Tasly enriches foreign portfolio [China Daily: US Edition]
The total value of the deal is $24 million plus royalties and Tasly will pay $3 million to initiate the project and participate in the third phase of clinical tests and research with EA. Tasly also announced that it will buy stock worth $20 million in Australia- based pharmaceutical maker Mesoblast Ltd on Tuesday. If the products are approved by th
7/21/18 - Trump plan fails to lower prescription drug prices
But Senate Democrats have since found that the company actually had several meetings, that drug-pricing policies were on the agenda and that a number of proposals Novartis pushed for made it into the White House plan. He called out Pfizer specifically, saying the company should be ashamed of itself. The tweet led to a phone call between the c
7/21/18 - US FDA Approves Krintafel (tafenoquine) for the Radical Cure of P. Vivax Malaria
GlaxoSmithKline issued the following news release:. GSK and Medicines for Malaria Venture today announced that the United States Food and Drug Administration has approved, under Priority Review, single-dose Krintafel for the radical cure of Plasmodium vivax malaria in patients aged 16 years and older who are receiving appropriate antimalarial thera
7/21/18 - Week Ahead In Pharmaceuticals - 14 Stocks To Watch (LCI, INSY, TBPH...)
Tilray Inc. made its debut on the Nasdaq Global Select Market on July 19, becoming the first cannabis company to go public on a U.S. major stock exchange. For Agios Pharmaceuticals Inc., it was a pleasant surprise when the FDA approved Tibsovo for treating relapsed or refractory acute myeloid leukemia patients with an IDH1 mutation on July 20, one
7/20/18 - "Silyl Etherified Derivatives of 5-Azacytidines in Carbohydrate Moiety" in Patent Application Approval Process (USPTO 20180179246)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors Sako, Magoichi; SUGIYAMA, Shinpei, filed on February 22, 2018, was made available online on July 5, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Ohara Pharmaceutical Co. L
7/20/18 - 2018 and Beyond: Spain Pharmaceutical & Healthcare Market Trends & Outlook Study to 2025 - ResearchAndMarkets.com
Spending on medicines and healthcare in Spain witnessed steady growth in 2017, reflecting strong potential for new medicine development, infrastructure building and new entry/expansion opportunities. This report focuses its attention on pharmaceutical market in Spain and presents market trends, drivers and challenges facing the R&D professionals,..
7/20/18 - 2018 and Beyond: United Kingdom Pharmaceutical & Healthcare Market Trends & Outlook Study to 2025 - ResearchAndMarkets.com
Spending on medicines and healthcare in United Kingdom witnessed steady growth in 2017, reflecting strong potential for new medicine development, infrastructure building and new entry/ expansion opportunities. This report focuses its attention on pharmaceutical market in United Kingdom and presents market trends, drivers and challenges facing the..
7/20/18 - 2018 Pharmaceutical Market Research Bundle Monoclonal Antibody Markets, CMOs, Bioprocessing Markets, Biosimilar Drug Markets - ResearchAndMarkets.com
By a News Reporter-Staff News Editor at Drug Week The "Pharmaceutical Market Research Bundle" report has been added to ResearchAndMarkets.com' s offering. This Market Research Bundle allow customers to experience savings while obtaining a large amount of research on topics of importance in pharmaceuticals. This bundle represents essential trends
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415